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A  previous  publication  (1)  on  the  biological  classification  of 
Friedl~tnder's bacillus reported the existence of at least three specific 
types and  a  heterogeneous group among these bacilli.  The group- 
ings, designated as Types A,  B,  and  C,  and  Group X,  are sharply 
defined and highly specific by a number of immunological reactions. 
In a later communication (2) it was stated that encapsulated strains 
are usually virulent, produce soluble specific substance, and as  anti- 
gen,  induce  the  formation  of type-specific antibodies which operate 
effectively both in test-tube reactions and in animal protection tests. 
Capsule-free strains, on the other hand, are avirulent, do not produce 
soluble specific  substance,  and as antigen stimulate only the undif- 
ferentiated  species  antibody.  Type-specific  antisera  react  irregu- 
larly with capsule-free strains; and the species-specific antisera,  while 
reacting with  capsule-free organismg regardless of type  derivations, 
do not react at all with encapsulated cells. 
The accumulated evidence on the serological reactions of Pneumo- 
coccus (3)  and Friedlitnder's bacillus  (1,  2, 4, 5)  discloses that both 
species  are  composed  of  specific  types  which  are  referable  to  the 
elaboration  of soluble specific  substance  by  the organisms.  Under 
certain conditions, the ceils degrade into capsule-free bacteria which, 
among other changes, show lack of virulence and capsule formation, 
loss of elaboration of specific  carbohydrate, and loss of type-specific 
antigenicity--all of which properties are the opposite of those which 
characterize their encapsulated antecedents.  In virtue of the strik- 
ing parallelism in the immunological behavior of Pneumococcus and 
Friedli~nder's bacillus it seemed of interest to project into the latter 
group  the principles which govern  the immunological relationships 
of the cell constituents of Pneumococcus. 
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The  comparative  immunological  studies  of  the  soluble  specific 
substance and the nucleoprotein  of Pneumococcus  (3) reveal that the 
soluble  specific  substance,  a  nitrogen-free  carbohydrate,  reacts 
specifically  with  antipneumococcus  serum  of  the  homologous  type. 
In the dissociated,  dissolved,  state,  it does not serve as antigen;  but 
in  the form in which it exists in the cell it functions antigenically to 
produce  type-specific  antibodies.  The  nucleoprotein,  on  the  other 
hand,  is  protein  in  nature  and  induces  in  the  animal an  antiserum 
which contains only the antiprotein  or common, species antibody. 
The present  study  is  concerned  with  the  immunological  relation- 
ships of cell constituents of Friedl~inder's bacillus and the occurrence 
of these  constituents in  culture  and  body fluids of infected  animals. 
Methods. 
Tke  Soluble Specific Substance.--Methods  for  the  fractionation  of  soluble 
specific  substance of Friedlgnder's bacillus have been described in papers from 
this laboratory (5).  It was shown at that time that carbohydrate derived from 
Strain E  (Type B) is dextrorotatory, shows an acid equivalent varying from 670 
to 716, is nitrogen-free, and on hydrolysis yields about 75 per cent reducing sugars. 
It reacts only in type-specific sera to a dilution of 1 to 4 million.  Purified,  nitro- 
gen-free  polysaccharides of Types A  and  B  prepared in  this  laboratory were 
utilized in the present study through the courtesy of Drs. Heidelberger and Goebel. 
The Nucleoprotegn.--Several methods were employed for the separation of the 
protein and none of the methods were entirely satisfactory.  The yield was usually 
small and the solutions underwent denaturation on keeping.  The method finally 
adopted, however, made use of non-encapsulated cells (since no difference could 
be shown between the protein derived from encapsulated and capsule-free cells, 
respectively).  The growth from the  surface of the  agar in  Blake bottles was 
washed off in sterile distilled  H20.  To this suspension NaOH was added to an 
ultimate  concentration  of  .005 N.  The  suspensions  were  frozen  and  thawed 
successively  a dozen times or more and then diluted 3--4 times with distilled  H~O 
and centrifuged.  The resultant supernatant was filtered, so that a sterile cell-free 
filtrate was obtained.  Precipitation was then effeeted with a minimum amount of 
N acetic acid and the precipitate was whirled down.  The supernatant was dis- 
carded and the precipitate was redissolved  in a minimum amount of. 01 ~ NaOPI. 
Usually acid precipitation and solution with alkali were repeated and the final 
product was made up in  .85 per cent NaC1.  All protein solutions were stand- 
ardized on the basis of nitrogen content. 
Immunological  Reactions.--The  method  of  immunization,  the  reactions  of 
agglutination  and precipitation  and protection test have been  described  in  an 
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EXPERIMENTAL. 
I.  The  Soluble  Specific  Substance.--(a)  Antigenic  Properties.-- 
Repeated observations already published from this laboratory leave 
no doubt that the chemically purified polysaccharide of Pneumococcus 
is non-antigenic.  Similar studies  (6)  of Zinsser, Mueller,  and their 
associates also record  the lack of antigenicity of "residue antigen" 
from a number of bacterial species.  The "residue antigen" of these 
investigators is  a  substance  which is  extracted  from  bacteria  and 
which bears a  definite relation to  the specific character of the bac- 
terial  cell. 
In the present study observations on the.antigenicity of the carbo- 
hydrate of Friedlitnder's bacillus are confined to the immunization of 
rabbits  with  the  polysaccharide  derived  from  Group  X.  In  this 
instance a  solution of bacterial  cells was prepared from an  encap- 
sulated  strain  and  it  consequently  contained  dissociated  soluble 
specific  substance.  Immunization with  this  product  even  in  the 
presence of nucleoprotein yielded no specific antibodies,  as  will be 
pointed out later.  Since  the results  from various  sources indicate 
that  bacterial polysaccharides are not antigenic, the lack of specific 
antibody response to a  solution containing both protein and carbo- 
hydrate is evidence of similar conditions in the case of Friedl~nder's 
bacillus, also.  At the same time it is clear that bacterial dissolution 
is accompanied by antigenic dissociation. 
(b)  Serological Properties.--It  has  been  previously demonstrated 
(1,  2,  4,  5)  that  the  polysaccharides  derived  from  Friedl~nder's 
bacillus react specifically with immune sera of the homologous type. 
(Cf.  in  this  connection Table  IV.)  In  fact,  sufficiently conclusive 
proof has been presented to show that just as has been shown with 
Pneumococcus, the soluble specific substance confers upon the cell its 
immunological type specificity. 
II.  The  Nucleoprotein.--(A)  Antigenic  Properties,--It  is  realized 
that  the  acetic acid-precipitable material represents more than the 
nucleoprotein of the bacterial cell, and that it is a mixture of proteins 
rather than a  single antigenic unit.  Nevertheless, for the purposes 
of the present study, this fact offers no  difficulty in either the per- 
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TABLE  I. 
Agglutination  of "S" Strains of Friedlander's Bacillus by Anti-P Sera. 
T 
Antigen encapsulated strain 
Type A.. 
~  C. 
Group X. 
Anti-P sera derived from 
Type A  Type  B  GroupX 
•  o 
-  --i_  ~  ..... 
A 
1:5 
++++ 
Anti-S sera--Type 
B  C 
--I 
1:5  1:5  ] 
_  _  ] 
++++  - 
-  ++++ 
!  X 
1:5 
m 
+++-~ 
I 
+  +  +  +  indicates complete, disc agglutination. 
* The figures represent  dilution of serum. 
TABLE  II. 
Agglutination  of "R" Strains of Friedl~inder's Bacillus by Anti-P Sera. 
Anti-P sera 
Type A 
"  B 
Group X 
Protein antigen 
from 
Type A 
"  B 
"  C 
Group X 
Type A 
"  B 
"  C 
Group X 
Type A 
"  B 
"  C 
Group X 
1:5  1:10 
4-++÷  4-4-++ 
++4-4-  4-+++ 
4-~  ~ ,~  4-4-4-+ 
4-+÷4-  4-4-++ 
4-+++ 
4-4-++ 
++++ 
++++ 
++++ 
-t-+-H- 
4-+++ 
4-+++ 
Final dilution of serum 
-I-+4-4-  4-4-++ 
~ ,~÷  4-4-++ 
++4-+  +++4- 
4-4-++ i 4-+-b+ 
1:20  1:40 
++++  ++++ 
+++4-  +++ 
++4-  4-4-4- 
++-t-4-  4-+÷4- 
4-+++  4-+++ 
÷+4-+  +4-4-+ 
++++  +++ 
4-+++  ++++ 
4-+++  4-4-4- 
4-4-++  -F-H-+ 
4-++  ++4- 
4-+++  4-4-+4- 
1:80 
q-b++ 
4-++ 
+4- 
++++ 
++++ 
+4-4-+ 
+++ 
--  +++÷ 
1:160  1:320 
++-~  +4-4-+ 
++  ++ 
+  + 
++++  4-4-++ 
+++  ++ 
+++  ++ 
++  ++ 
++++  ++++ 
++  +  + 
+++  ++ 
++  ++  + 
++-H  ++  + 
l'qormal 
serulll 
I:5 
B 
+  +  +  +  indicates  complete  agglutination;  +  +  +,  marked  agglutination, 
+  +, moderate agglutination; +, slight agglutination. 
bits  were  immunized  to  the  protein  isolated  from  representative 
strains  of  Types  A  and  B  and  Group  X.  The  immune  sera  were 
tested for agglutinins,  precipitins,  and protective  antibodies. 
(a)  Agglutinins.--Antiprotein  sera  do  not  contain  type-specific LOUIS  A.  JULIANELLE  739 
agglutinins for encapsulated strains of Friedlgnder's bacillus.  Evi- 
dence for this statement is  found in  Table  I  where it is  seen  that 
antisera prepared by immunization with protein derived from sero- 
logically different strains do not react with the encapsulated cell of 
either homologous or heterologous type. 
It  will  be  recalled  that  capsule-free  (R)  strains  of  Friedl~nder's 
bacillus (2)  stimulate the formation of the common, undifferentiated 
TABLE  III. 
Agglutination by Anti-P Sera of Suspensions of Friedl~nder's Bacillus Decapsulated 
by Porges' Method. 
Anti-P serum 
derived from 
Type A 
"  B 
Group X 
Antigen dezived 
from 
Type A 
"  C 
Group X 
Gram* 
Type A 
u  C 
Group X 
Gran. 
Type A 
~  ]3 
~  C 
Group X 
Graxt, 
1:50 
÷÷+ 
+÷÷+ 
÷÷ 
+÷+ 
++ 
++ 
++++ 
;?÷ 
++ 
+ 
++ 
++ 
Dilution of serum 
1:100 
+++ 
++++ 
+++ 
+++ 
++ 
+++ 
++++ 
+++ 
++++ 
++ 
+÷ 
-~++÷ 
+ 
~-÷-- 
÷÷ 
1:250  2:5~ 
++++  ++++ 
++++  ++++ 
+++  ++ 
++++  ++++ 
+ 
++++  ++++ 
++++  +++ 
+++  ++ 
++++  ++++ 
+ 
++++  ++++ 
++++  +++ 
+++  ++ 
++++  ++++ 
++  + 
1:1000 
+÷+ 
÷÷+ 
÷ 
÷÷+ 
m 
++++ 
++ 
+ 
+++ 
++++ 
+ 
++ 
+++ 
*  This organism is a strain of granuloma bacillus--isolated from an infection 
of granuloma inguinale. 
species  antibody; but  that they are unable to provoke type-specific 
antibodies.  Accordingly,  it  seemed  pertinent  to  determine  the 
reaction  of  antiprotein  sera  on  the  non-encapsulated strains.  The 
results of the reactions are given in Table II.  It is seen that capsule- 
free cells derived from any of the serologically different types agglu- 
tinate equally well in all the antiprotein sera.  The agglutination is 740  CELL  CONSTITUENTS  OF  ENCAPSULATUS  PNEUMONI.~ 
characteristic  of  the  R  cells  (2)  and  occurs  at  a  high  dilution  of 
serum.  Antiprotein  sera,  in  other  words,  behave  in  this  respect 
similarly  to  anti-R  sera.  It  was  to  be  expected,  then,  that  anti- 
protein  sera  would  agglutinate,  also,  suspensions  of  FriedlRnder's 
bacilli after decapsulation by Porges' method.  Earlier observations 
(2)  pointed out  the  serological similarity of capsule-free strains  ob- 
tained by cultural and chemical means.  Table III reveals  that  sus- 
pensions  of  encapsulated  cells  treated  as  Porges  recommends are 
agglutinated in antiprotein sera just as are the "R"  strains. 
TABLE  IV. 
Precipitation  of the  Soluble  Specific  Substance 
P  Sera. 
of Friedli~nder's  Bacillus by  Anti- 
S©rum 
Type A  (P)  ............... 
~  B  ~  ............... 
Group X"  ............... 
Type A (S) ............... 
Normal .................. 
Soluble specific  substance of  FriedlRnder's  bacillus 
Type  A  Type  B 
~1  ml  --  -- 
Ii 
--i 
--i 
mm 
....  -! 
--i  N 
+1++ ++ + 
--t  -- 
..... I-i 
--r 
i 
ii+i 
m 
+++ ++ 
+  +  +  indicates  compact disc precipitation  with  clear  supernatant;  +  +  +, 
marked  disc precipitate;  +  +, thin film-like  scale;  +, ground glass turbidity. 
The figures represent dilution in thousands. 
(b)  Precipitins.-~-It  has  been  shown  that  type-specific precipitins 
are induced only by the encapsulated cell.  Added confirmation of 
this fact is derived from the observation that antiprotein sera do not 
react with the specific polysaccharides of Friedl~inder's bacillus.  This 
is evident from the results presented in Table IV,  It is definite that 
none of the antiprotein sera are able to cause precipitation of carbo- 
hydrate isolated from strains of Type A or B. 
That antiprotein sera react with capsule-free strains of Friedl~inder's 
bacillus  constitutes  direct  evidence of  the  presence  of  the  species 
antibody.  That  the  species  antibody  is  in  reality  an  antiprotein LOreS  A.  Jm~IA~-~T,T,r,  741 
TABLE  V. 
Precipitation  by Anti,-P  Sera of tke  "2Vucleoprotein" of Friedli~nder's Bacillus and 
Allied Organisms. 
Ant~en* 
Type A protein 
Type B protein 
Type C protein 
Group X protein 
B. a~rogenes protein 
B. coli protein 
Granuloma  bacillus 
protein 
Anti-P serum 
from 
Type A 
"  B 
Group X 
Type A 
"  B 
Group X 
Type A 
"  ]3 
Group X 
Type A 
Group X 
Type A 
tc  B 
Group X 
Type A 
"  B 
Group X 
Type A 
"  ]3 
Group X 
Ultimate dilution of protein 
200  1000  2000  I  4000  8000  16,000  32,000 
I 
4--I-4  -I--k+  ++  [  +-F  +  ~  - 
i 
I1|  ~I~  q-+  [,,  +  -  --  - 
500  2500  5000  t0,00~  0,00(  40,000  80,000 
II  LIII  Ill  ++  +  ~  -- 
q-l-  +-l-  I'II  III  4-A-I  Ill  + 
+-H  +++  ++  +  ~  -  - 
200  1000  2000  4000  8000  16,000  32,000 
++  ++  -I--I-  +  +  ,~  - 
-I-4-  ,Ill  II  III  ±''  ~''  -I-  I  I  I  I  I  I 
-  +  -l-+  -4-4-  +  -  - 
500  2500  5000  LO,O0(  :0,00~  40,000  80,000 
I 
II  r,  lll  I14  4"+  +  '~  -- 
++  ++  +-H  I~.1  -H-  ++ 
-4-4-  ++  +  ,~  -  - 
500  2500  5000  0,000  0,00(  40,000  80,000 
-I-4-  +  +  ,~  -  -  - 
q-l-  +  +  ~  -  -  - 
-H-  +  ~  .... 
300  1500  3000  6000  2,00(  24,000  48,000 
-H-  +  +  =~  -  -  - 
++  ++  +  +  ~  _  _ 
-H-  -I-I-  +  +  -  -  - 
200  I000  2000  4000  8000  16,000  32,000 
++  -l--b  +  +  -  -  - 
-H-  ++  +A-  +  +  -  - 
+  +  ,~  .... 
+-4-++  indicates  heavy  precipitation,  supernatant  clear;  +-4--4-,  marked 
precipitation with cloud;  -b +, marked cloud, no precipitation; +,  cloud; :t:, faint 
cloud. 
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antibody  is  evidenced  by  the  reaction  of  protein  precipitation  in 
antiprotein  sera.  The  results  of  these  reactions  are  presented  in 
Table V.  It is seen that sera prepared against protein isolated from 
three serologicany different strains cause the precipitation of protein 
derived from any of the four different strains.  It  becomes  obvious 
therefore  that  nucleoprotein  induces  the  formation  of  species anti- 
bodies which cause agglutination of capsule-free ceils and precipita- 
tion of protein and that the reactions  exhibit none of  the  type  rela- 
tionships. 
In addition, Table V  reveals that antiprotein sera of Friedliinder's 
bacillus reacts  with protein  derived  from B.  aerogenes,  B.  coli,  and 
granuloma  bacillus.  Stated  in  another  way  the  protein  of  Fried- 
TABLE  VI. 
Protection  Offered by  Anti-P  Sera  against  Infection  with  Friedl~tnder's Bacillus 
(Type A). 
Type A 
encapsulated 
culture 
.001 
.0001 
.00001 
.000001 
.0000001 
Antiserum derived from 
Type A  Type B 
Amount  Result  Amount  !  Result 
CG. 
.2 
.2 
.2 
.2 
D. 20 
"  16 
"  39 
"  39 
t'C. 
.2 
.2 
.2 
.2 
D. 19 
"  15 
"  16 
"  43 
Virulence 
controls 
D. 24 
"  39 
"  65 
D.  indicates  death,  the  numerals  representing  the  number  of  hours  before 
death  occurred. 
lgnder's bacillus bears  a  definite  serological  relationship to proteins 
of closely allied species.  This lends  considerable  assistance  in  the 
interpretation  of  the results  of  former investigators who  have  ob- 
served that  anti-Friedl~tnder sera  caused agglutination of  23.  rhino- 
sderomatis  (7-10),  B.  aerogenes (11),  typhoid  (12),  and  granuloma 
bacillus  (13),  etc.  The  explanation  of  such  cross-agglutinations 
appears to depend upon the fact that immunization with non-encap- 
sulated strains or prolonged immunization with encapsulated strains 
stimulates the formation of agglutinins which act not only on R  ceils LOUIS A.  IULIANELLE  743 
of Friedl~tnder's bacillus, but on R  cells of closely related  species, as 
pointed out  above. 
IlL  Protection.--Immune  sera  prepared  by  immunization  with 
encapsulated  Friedl~tnder's  bacilli  confer  upon  white  mice  specific 
protection  against  infection by strains  of the homologous type  (1). 
TABLE  VII. 
Protection  Offered  by  Anti-P  Sera  against  Infection  by  Friedlignder's  Bacillu~ 
(Type B). 
Type B 
encapsulated 
culture 
.001 
.0001 
.00001 
.000001 
.0000001 
Anti-P serum derived from 
Type A  Type B 
Amount  Result  Amount  Result 
CO. 
,2 
,2 
.2 
,2 
D. 16 
"  16 
"  39 
"  39 
CC. 
.2 
.2 
.2 
.2 
D. 15 
"  15 
"  20 
"  67 
Virulence 
controls 
D. 16 
"  39 
"  39 
D. indicates death,  the numerals representing the number of hours  before 
death occurred. 
TABLE  VIII. 
Precipitation of the Nucleoprotein of Friedl~nder's  Bacillus by Anti-S Sera. 
Frledlt~nder protein derived from 
Anfi-S Friedl~nder sera  Type A  Type B 
*600  6000  1200  12,000 
Type  A ...................  ++  q-  -k  +-b 
"  B ...................  +  --  q-  -- 
"  C ...................  ++  +  ++  -t- 
Group X  ..................  +  -  +  +  - 
Type C 
900  9000 
++  + 
.4- 
++  + 
I  +  ~- 
Group X 
500  5000 
++  + 
+  - 
++  + 
+  - 
* These figures represent the dilution of protein. 
Immunization with non-encapsulated cells, however, yields no protec- 
tive  antibodies  (2).  Protective  substances,  therefore,  accompany 
type-specific antibodies.  It was anticipated then that lacking type- 
specific agglutinins and precipitins, Friedl~inder antiprotein sera would 
afford no  passive  protection  against  active infection.  That  this is 744  CELL  CONSTITUENTS  OF  ENCAPSULATUS  PNEU~[ONI~ 
actually the case is borne out by the data given in Tables VI and 
VII.  The lack of any protective action by antiprotein sera against 
infection with virulent strains of homologous and heterologous types 
is striking. 
(b)  Serological  Properties.-- 
1.  Precipitation of Protein in Anti-S Sera.--Anti-FriedlAnder  sera 
resulting from immunization with encapsulated strains are dominantly 
type-specific.  Consequently anti-S  sera contain negligible amounts 
TABLE  IX. 
Precipitation by A nti-R S era of the " N ucleoprotein"  of Friedlander' s Bacillus. 
Antigen 
Type Aprotein 
Type B protein 
Type C protein 
Group X protein 
Anti-R serum 
from 
Type A 
~  B 
Group X 
Type A 
~  B 
Group X 
Type A 
Group X 
Type A 
Group X 
200  1000 
+++ +++ 
+++  ++ 
++  + 
500  2500 
+++  ++ 
++  ++ 
++  + 
200  1000 
++  + 
++  + 
++  + 
500  2500 
+++1  ++ 
++2+++2+ 
Dilution of protein 
2000  4000  8000 
++  ++  + 
++  +  - 
+  4-  - 
5000  10,000  20,000 
3  W  ~  __ 
2000  4000  8000 
-F  4-  -- 
5000  10,000  20,000 
++  +  - 
16,000 
40,000 
16,000 
40,000 
32,000 
80,000 
32,000 
80,000 
of antiprotein as has been pointed out previously (2) by the agglutina- 
tion of R cells in anti-S sera.  In virtue of the presence of antiprotein, 
such sera may cause precipitation of protein.  This fact is illustrated 
in  Table VIII.  Type A  anti-Friedl~inder serum definitely contains 
the species antibody, while the remaining type sera contain traces or 
none at all. 
2.  Precipitation  of Protein  in  Anti-R  Sera.--Capsule-free  strains 
of Friedliinder's bacillus are agglutinated in antiprotein sera  (Table LOUIS  A.  /ULIAN'ELLE  745 
II).  Evidence of the reciprocal nature of this reaction was obtained 
in  the precipitation  of protein by anti-R sera.  It is  seen from the 
results presented in Table IX  that  anti-R sera cause the precipita- 
tion  of  protein  from  Friedliinder's  bacillus  of  the  different  types. 
The  conclusion  can  be  drawn,  therefore, that the common species 
antibody  reacts  with  the  undifferentiated antigen  of  Friedl~inder's 
bacillus whether the antigen is in the form of non-encapsulated cells 
or in the form of dissolved protein. 
TABI2K  X. 
Precipitation of Friedlllnder Protein by Anti-P Sera after Adsorption of the Species 
Antibody by R Strains. 
Antigen protein derived from 
Type A ................ 
Group X ............... 
Anti-P serum (Type A) after  adsorption  by R strains  derived  from 
encapsulated  strains  of 
Type A  Group X  Type B  Type C 
g 
I- 
* The figures represent the dilution of protein. 
(c)  Precipitation  of  Protein  in  Antiprotein  Sera.--It  has  been 
shown above that protein derived from any of the serological types is 
precipitated in all antiprotein sera.  (Cf. Table IV.) 
Adsorption of Antibodies in Antiprotein Sera by Non-Encapsulated (R) 
Strains of Friedlander's Bacillus. 
Because agglutination  of R  cells  occurs in  antiprotein  sera,  and 
precipitation of protein is obtained in anti-R sera, experiments were 
conducted to  gain  information concerning the identity of the anti- 
body involved in  both  reactions.  Each antiprotein  serum was  ad- 
sorbed with heat-killed suspensions of R  cells derived from encapsu- 
lated strains of Types A, B, and C, and Group X.  Adsorption was 
continued until  all  the agglutinins were removed for the adsorbing 746  CELL CONSTITUENTS OF  ENCAPSULATUS PNEUMONI.~E 
strain.  It was found that removal of agglutinins by one strain  ad- 
sorbed the agglutinins for the remaining R  strains also.  Moreover, 
the loss of agglutinins by adsorption was accompanied by a  loss of 
precipitins.  A  typical protocol is presented in Table X.  It is clear 
that adsorption of a serum resulting from immunization with protein 
derived from a  strain of Type A, for example, with any of the four 
"R"  strains  deprives  the  serum  of  precipitins  for  protein  derived 
from any of the types.  It appears therefore that the undifferentiated 
species antibody is  the same antibody whether it  occurs  in  anti-R 
or  antiprotein  sera. 
TABLE XI. 
Occurrence of Soluble Specific Substance in Culture Filtrate. 
Friedl~nder Bacilli. 
Stra~ 
Type A  ........ 
~c  B  ........ 
~c  C  ........ 
Group X ....... 
Dilution of filtrates 
After 4 hrs.  After 8 hrs.  Aft 
+-__  +  +  +++ 
i  :  +  ++1+  ++ 
After 12 hrs. 
!++ +  - 
i+  -- 
,  Mter  24 hrs. 
++++++++ 
i++++  +++ 
i++++++++  ++++  ++ 
o 
Occurrence  of  Soluble  Specific  Substance  in  Culture  Filtrates  of 
Friedliinder'  s  ~acillus. 
It  has  been  shown  by  Dochez  and  Avery  (14)  that  the  soluble 
specific substance  of  Pneumococcus is  demonstrable  in  culture  fil- 
trates,  and that the progressive increase of the carbohydrate bears a 
striking  relation  to  the growth curve of the  culture.  Their results 
show clearly that the soluble specific substance is  a  product of meta- 
bolic activity rather than a product of cell disintegration. 
In similar fashion,  the polysaccharide of Friedl~tnder's bacillus  is 
demonstrable  in  actively  growing  cultures.  Cell-free  filtrates  ob- 
tained  at  different  intervals  during  the  growth  are  precipitated 
specifically by anti-Friedl~nder sera.  The data submitted in Table 
XI  show that in  some instances specific carbohydrate is present in 
filtrates  as  early as 4  hours  after growth has  been  initiated.  The LOUIS  A.  JULIANELLE  747 
amount of the carbohydrate increases rapidly so that after 24 hours' 
growth a definite reaction may be obtained in culture filtrate in dilu- 
tion of 1:20, and in one case (Type A) even in a dilution of 1:50. 
Occurrence  of Protein  in  Culture  Filtrates  of Friedliinder's  Bacillus. 
The type specificity of anti-Friedl/tnder sera depends in part upon 
the  integrity, and  the  absence  of  R  cells  in  the  culture  used for 
immunization.  It  becomes of importance,  therefore,  to  determine 
the rapidity of the disintegration of Friedlander's bacilli.  Dissocia- 
tion may be  estimated by  the presence of the common or protein 
antigen.  Accordingly an analysis of the protein content of culture 
filtrates of Friedl~nder's bacillus was made by the usual protein pre- 
TABLE  XII. 
Occurrence ~ Protein in Culture Filtrates ~ Friedl~nder Bacilli. 
Stra~ 
Type A ................. 
~  C ...........  ..o.°. 
Group X  ............... 
Dilution  of filtrates 
At 12 hrs.  At 24 hrs. 
1:1  :10  1:1 
At 72 hrs.  5  lays  9 days 
rio  1:1  1:10  1:1  1:10  1:1  1:5  1:10 1:20 
_  _  _  _  +  4- 
--  -b+'-k-~  -{-  - 
-  +++  4-  - 
-  +-{-  -b  4-  - 
cipitation test.  As brought out in Table XII, no protein was demon- 
strated in culture filtrates  after  5  days'  growth.  On  the  9th day, 
precipitation  of  protein  was  obtained  in  all  the  filtrates  studied. 
In  contrast  to  the  carbohydrate  which  is  elaborated  during  the 
period of active growth, the protein is demonstrable after this period 
and when cell disintegration takes place. 
This fact becomes of great significance in immunization with sus- 
pensions of Friedl~inder's bacillus.  Despite the fact that both dis- 
integration and R  cells are absent in the cultures used for immuniza- 
tion, anti-Friedl~inder sera may contain variable amounts of protein 
antibody.  This is evidence that the body defenses not only engender 
type-specific antibodies, but also include a mechanism which causes a 
cleavage or disintegration of the specific antigen. 748  CELL CONSTITUENTS  OF ENCAPSULATUS  PNEUM01~ 
Occurrence  of  Soluble  Specific  Substance  in  Friedlgnder  Infeclions. 
The soluble specific substance of Pneumococcus has  been  demon- 
strated in the serum and urine of patients during pneumonia by Dochez 
and  Avery  (14).  Blake  (15)  has  shown  that  this  is  also  a  fact  in 
pneumonia due to FriedlAnder's bacillus.  This is the only reference 
of its kind concerning Friedl~nder infection which has  come to  our 
attention.  In  the  present  study  experiments  were  performed  to 
detect  specific  carbohydrates  in  rabbits  infected  by  intraperitoneal 
injections  of Friedl~inder's  bacilli.  The  urine  and  blood  of  the  in- 
fected rabbits were collected and tested for soluble specific substance 
TABLE  XIII. 
Occurrence of Soluble Specific Substance in the Blood and Urine of Animals Infected 
with Friedlgnder's Bacilli. 
Type ofknfection 
Type B 
"  C 
Body fluid 
Serum 
Urine 
Serum 
Urine 
Dilution of fluid 
1:1  1:5  1:10 
++ 
+ 
+++ 
++ 
+ 
++ 
+ 
J 
+ 
m 
The precipidn reacdon was obtained only in homologous immune serum. 
by the usual precipitin technique.  It is seen from Table XIII  that 
the  specific polysaccharide  of  Friedl~nder bacilli  is present  in  both 
urine  and  serum  of  rabbits,  and  is  demonstrable  within  18  hours 
after/nfection. 
DISCUSSION. 
The soluble specific substance of Friedl~nder's bacillus endows the 
cell with type specificity, and is separable from the bacterial cell as a 
pure,  nitrogen-free polysaccharide.  When  dissociated from the cell, 
it does not function as antigen, but in the form in which it exists in 
the cell it  stimulates  the formation of antibodies which cause  type- 
specific  agglutination  of  encapsulated  cells,  precipitate  the  carbo- 
hydrate derived from organisms of the homologous type,  and afford LOUIS  A.  JULIANELLE  749 
passive protection in white mice against infection by bacilli of the 
same type.  As reacting substance, it is precipitated only in antisera 
resulting from immunization with encapsulated strains  from which 
it is derived. 
The nucleoprotein is separable from dissolved Friedl~nder's bacilli 
by precipitation with acetic acid in the cold.  This constituent differs 
in nature and in serological behavior from the soluble specific  sub- 
stance.  It is protein in nature  and is  a  common, undifferentiated 
constituent of all types.  It is antigenic and provokes in the animal 
the common protein or species antibody.  The species antibody does 
not react with encapsulated bacilli of any type nor with the soluble 
specific  substance  of either homologous or heterologous types,  and 
does not protect against infection with Friedl~nder's bacillus.  Anti- 
protein  sera,  however, cause agglutination of  capsule-free cells  de- 
rived from any of the serological types by either cultural or chemical 
methods; and they react also with protein from all types.  Moreover, 
the protein antibody is of a sufficiently general nature to react with 
protein from allied bacteria.  In this fact resides the explanation for 
the  confusing  cross-agglutination  reactions  obtained  with  related 
organisms by former workers.  That the protein antibody is of more 
or less  common occurrence among other  species of  bacteria  gains 
evidence from  the  results  of numerous investigators.  The  studies 
from this laboratory show this with Pneumococcus, and the work of 
Lancefield (16),  Hitchcock (17),  and Tunnicliff (18) discloses  a  dis- 
tinct  serological relationship between various species  of  the  Gram- 
positive cocci.  The contributions of Dopter  (19) and Eberson  (20) 
depict  similar  relationships  among  the  Gram-negative  cocci,  and 
Smith and TenBroeck (21) and Felix (22) offer  comparable data for 
members of the typhoid-colon group. 
Antisera  prepared  by  immunization with  protein  or  with  a  de- 
graded  non-encapsulated  1~  culture  contain  antibodies  which  are 
identical in their immunological reactions. 
The presence of soluble specific  substance in filtrates of growing 
cultures suggests that it is a product of growth activity of the cell. 
The presence of protein in filtrates of old cultures only, indicates that 
it is a product of cell autolysis and disintegration. 750  CELL CONSTITUENTS OF  ENCAPSULATUS rNEUMONI2E 
CONCLUSIONS. 
1.  The  soluble  specific  substance  of Friedl~nder's  bacillus  is  non- 
antigenic when dissociated from the cell.  It is different for each type 
and it is highly  reactive in  the corresponding  anti-S  serum. 
2.  The  nucleoprotein  is  antigenic,  induces  the  species  or  protein 
antibody  which  reacts  with  capsule-free  cells  and  protein  derived 
from all types.  Antiprotein  sera do not react with either the encapsu- 
lated  cell  or  the  polysaccharide  derived  from  it,  and  they  offer no 
protection  against  infection. 
3.  Anti-R  and  antiprotein  sera are identical  in  their  behavior. 
4.  The  carbohydrate  of  Friedliinder's  bacillus  is  demonstrable  in 
filtrates  of actively  growing  cultures  and  in  the  blood and  urine  of 
infected  animals. 
5.  The protein  is demonstrable  in filtrates  of only old,  disintegrat- 
ing cultures. 
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